This is a routine 10b5-1 plan sale with no new signal. Monitor for any acceleration of insider selling outside the plan or changes in the plan's terms, but no immediate trading action warranted.
Price Chart
Executive Summary
Officer Lillie James Woodruff filed a Form 144 notice to sell 22,082 shares of MapLight Therapeutics common stock, valued at approximately $287,508, under a pre-arranged 10b5-1 trading plan adopted on December 29, 2025. This is a routine continuation of an existing plan, with prior sales totaling ~70,695 shares since May 2026. The filing carries no new material information.
Key Facts
- Officer Lillie James Woodruff intends to sell 22,082 shares of MPLT common stock.
- Estimated market value of proposed sale: $287,507.64.
- Sale is pursuant to a 10b5-1 trading plan adopted on December 29, 2025.
- Prior sales under the same plan since May 2026 total approximately 70,695 shares.
- Shares to be sold are from vested RSUs acquired on July 18, 2025.
Financial Impact
Proposed sale of $287,508 represents approximately 0.05% of MPLT's $590M market cap — immaterial.
Risk Factors
- None material from this filing; the sale is pre-planned and small relative to market cap.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (MPLT) — Batch item 1 | 0001974158-26-000093 |
| Document: 0001974158-26-000093-index.html | 0001974158-26-000093 |
| Document: 0001974158-26-000093.txt | 0001974158-26-000093 |
| 144 Filing (MPLT) — Batch item 4 | 0001974158-26-000093 |
| Document: 0001974158-26-000093-index.html | 0001974158-26-000093 |
| Document: 0001974158-26-000093.txt | 0001974158-26-000093 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | Insider Cluster | $8.00 | awaiting T+20 | — | $7.66 (+4.25%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Oct 15, 2026 11d ago | 144 | $7.70 | awaiting T+20 | — | $7.66 (−0.52%) |
Sep 24, 2026 4w ago | EFFECT | $10.76 $8.25 | ▼ −23.33% | ▼ −22.91% | $7.66 (−28.81%) |
Sep 18, 2026 5w ago | S-1/A | $10.90 $8.00 | ▼ −26.61% | ▼ −25.70% | $7.66 (−29.72%) |
Aug 4, 2026 11w ago | Insider Cluster | $12.92 $13.06 | ▲ +1.08% | ▲ +1.69% | $7.66 (−40.71%) |
Aug 3, 2026 12w ago | 144 | $12.94 $13.31 | ▲ +2.86% | ▲ +4.10% | $7.66 (−40.80%) |
Jul 30, 2026 12w ago | 144 | $13.02 $12.60 | ▲ +3.23% | ▲ +6.21% | $7.66 (+41.17%) |
Jul 28, 2026 12w ago | Insider Buy | $15.02 $12.86 | ▼ −14.38% | ▼ −19.40% | $7.66 (−49.00%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers